190 related articles for article (PubMed ID: 33882688)
1. ADAM17 Boosts Cholesterol Efflux and Downstream Effects of High-Density Lipoprotein on Inflammatory Pathways in Macrophages.
Kothari V; Tang J; He Y; Kramer F; Kanter JE; Bornfeldt KE
Arterioscler Thromb Vasc Biol; 2021 Jun; 41(6):1854-1873. PubMed ID: 33882688
[TBL] [Abstract][Full Text] [Related]
2. Apolipoprotein AI and high-density lipoprotein have anti-inflammatory effects on adipocytes via cholesterol transporters: ATP-binding cassette A-1, ATP-binding cassette G-1, and scavenger receptor B-1.
Umemoto T; Han CY; Mitra P; Averill MM; Tang C; Goodspeed L; Omer M; Subramanian S; Wang S; Den Hartigh LJ; Wei H; Kim EJ; Kim J; O'Brien KD; Chait A
Circ Res; 2013 May; 112(10):1345-54. PubMed ID: 23501697
[TBL] [Abstract][Full Text] [Related]
3. Phytosterols differentially influence ABC transporter expression, cholesterol efflux and inflammatory cytokine secretion in macrophage foam cells.
Sabeva NS; McPhaul CM; Li X; Cory TJ; Feola DJ; Graf GA
J Nutr Biochem; 2011 Aug; 22(8):777-83. PubMed ID: 21111593
[TBL] [Abstract][Full Text] [Related]
4. HDL particle size is a critical determinant of ABCA1-mediated macrophage cellular cholesterol export.
Du XM; Kim MJ; Hou L; Le Goff W; Chapman MJ; Van Eck M; Curtiss LK; Burnett JR; Cartland SP; Quinn CM; Kockx M; Kontush A; Rye KA; Kritharides L; Jessup W
Circ Res; 2015 Mar; 116(7):1133-42. PubMed ID: 25589556
[TBL] [Abstract][Full Text] [Related]
5. USF1 deficiency alleviates inflammation, enhances cholesterol efflux and prevents cholesterol accumulation in macrophages.
Ruuth M; Soronen J; Kaiharju E; Merikanto K; Perttilä J; Metso J; Lee-Rueckert M; Taskinen MR; Kovanen PT; Öörni K; Olkkonen VM; Jauhiainen MS; Laurila PP
Lipids Health Dis; 2018 Dec; 17(1):285. PubMed ID: 30545366
[TBL] [Abstract][Full Text] [Related]
6. ABCG1 deficiency in mice promotes endothelial activation and monocyte-endothelial interactions.
Whetzel AM; Sturek JM; Nagelin MH; Bolick DT; Gebre AK; Parks JS; Bruce AC; Skaflen MD; Hedrick CC
Arterioscler Thromb Vasc Biol; 2010 Apr; 30(4):809-17. PubMed ID: 20110576
[TBL] [Abstract][Full Text] [Related]
7. CD36-mediated cholesterol efflux is associated with PPARgamma activation via a MAPK-dependent COX-2 pathway in macrophages.
Bujold K; Rhainds D; Jossart C; Febbraio M; Marleau S; Ong H
Cardiovasc Res; 2009 Aug; 83(3):457-64. PubMed ID: 19377069
[TBL] [Abstract][Full Text] [Related]
8. 9-cis β-Carotene Increased Cholesterol Efflux to HDL in Macrophages.
Bechor S; Zolberg Relevy N; Harari A; Almog T; Kamari Y; Ben-Amotz A; Harats D; Shaish A
Nutrients; 2016 Jul; 8(7):. PubMed ID: 27447665
[TBL] [Abstract][Full Text] [Related]
9. Haloperidol inhibits the development of atherosclerotic lesions in LDL receptor knockout mice.
van der Sluis RJ; Nahon JE; Reuwer AQ; Van Eck M; Hoekstra M
Br J Pharmacol; 2015 May; 172(9):2397-405. PubMed ID: 25572138
[TBL] [Abstract][Full Text] [Related]
10. Adipocyte modulation of high-density lipoprotein cholesterol.
Zhang Y; McGillicuddy FC; Hinkle CC; O'Neill S; Glick JM; Rothblat GH; Reilly MP
Circulation; 2010 Mar; 121(11):1347-55. PubMed ID: 20212278
[TBL] [Abstract][Full Text] [Related]
11. Reduction in dietary omega-6 polyunsaturated fatty acids: eicosapentaenoic acid plus docosahexaenoic acid ratio minimizes atherosclerotic lesion formation and inflammatory response in the LDL receptor null mouse.
Wang S; Wu D; Matthan NR; Lamon-Fava S; Lecker JL; Lichtenstein AH
Atherosclerosis; 2009 May; 204(1):147-55. PubMed ID: 18842266
[TBL] [Abstract][Full Text] [Related]
12. ApoE-dependent modulation of HDL and atherosclerosis by G2A in LDL receptor-deficient mice independent of bone marrow-derived cells.
Parks BW; Srivastava R; Yu S; Kabarowski JH
Arterioscler Thromb Vasc Biol; 2009 Apr; 29(4):539-47. PubMed ID: 19164809
[TBL] [Abstract][Full Text] [Related]
13. P2X
Peikert A; König S; Suchanek D; Rofa K; Schäfer I; Dimanski D; Karnbrock L; Bulatova K; Engelmann J; Hoppe N; Wadle C; Heidt T; Albrecht P; von Garlen S; Härdtner C; Hilgendorf I; Wolf D; von Zur Mühlen C; Bode C; Zirlik A; Duerschmied D; Merz J; Stachon P
Sci Rep; 2022 Feb; 12(1):2801. PubMed ID: 35181718
[TBL] [Abstract][Full Text] [Related]
14. Liver ABCA1 deletion in LDLrKO mice does not impair macrophage reverse cholesterol transport or exacerbate atherogenesis.
Bi X; Zhu X; Duong M; Boudyguina EY; Wilson MD; Gebre AK; Parks JS
Arterioscler Thromb Vasc Biol; 2013 Oct; 33(10):2288-96. PubMed ID: 23814116
[TBL] [Abstract][Full Text] [Related]
15. Statin-induced decrease in ATP-binding cassette transporter A1 expression via microRNA33 induction may counteract cholesterol efflux to high-density lipoprotein.
Niesor EJ; Schwartz GG; Perez A; Stauffer A; Durrwell A; Bucklar-Suchankova G; Benghozi R; Abt M; Kallend D
Cardiovasc Drugs Ther; 2015 Feb; 29(1):7-14. PubMed ID: 25749868
[TBL] [Abstract][Full Text] [Related]
16. Coffee consumption enhances high-density lipoprotein-mediated cholesterol efflux in macrophages.
Uto-Kondo H; Ayaori M; Ogura M; Nakaya K; Ito M; Suzuki A; Takiguchi S; Yakushiji E; Terao Y; Ozasa H; Hisada T; Sasaki M; Ohsuzu F; Ikewaki K
Circ Res; 2010 Mar; 106(4):779-87. PubMed ID: 20075335
[TBL] [Abstract][Full Text] [Related]
17. Apolipoprotein AI) Promotes Atherosclerosis Regression in Diabetic Mice by Suppressing Myelopoiesis and Plaque Inflammation.
Barrett TJ; Distel E; Murphy AJ; Hu J; Garshick MS; Ogando Y; Liu J; Vaisar T; Heinecke JW; Berger JS; Goldberg IJ; Fisher EA
Circulation; 2019 Oct; 140(14):1170-1184. PubMed ID: 31567014
[TBL] [Abstract][Full Text] [Related]
18. Structure-function relationships in reconstituted HDL: Focus on antioxidative activity and cholesterol efflux capacity.
Cukier AMO; Therond P; Didichenko SA; Guillas I; Chapman MJ; Wright SD; Kontush A
Biochim Biophys Acta Mol Cell Biol Lipids; 2017 Sep; 1862(9):890-900. PubMed ID: 28529180
[TBL] [Abstract][Full Text] [Related]
19. LAL (Lysosomal Acid Lipase) Promotes Reverse Cholesterol Transport In Vitro and In Vivo.
Bowden KL; Dubland JA; Chan T; Xu YH; Grabowski GA; Du H; Francis GA
Arterioscler Thromb Vasc Biol; 2018 May; 38(5):1191-1201. PubMed ID: 29599133
[TBL] [Abstract][Full Text] [Related]
20. Cholesterol reduction and atherosclerosis inhibition by bezafibrate in low-density lipoprotein receptor knockout mice.
Inaba T; Yagyu H; Itabashi N; Tazoe F; Fujita N; Nagashima S; Okada K; Okazaki M; Furukawa Y; Ishibashi S
Hypertens Res; 2008 May; 31(5):999-1005. PubMed ID: 18712055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
